STOCKHOLDERS' DEFICIT (Details Narrative)	1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 31, 2017 USD ($) Investor shares	Dec. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 USD ($) $ / shares shares
Authorized Capital Stock
Common stock, shares authorized (in shares) | shares			500,000,000	500,000,000
Common stock, par value (in Dollars per share) | $ / shares			$ 0.001	$ 0.001
Series A convertible preferred stock, shares authorized (in shares) | shares			2,000,000	2,000,000
Series A convertible preferred stock, par value (in dollars per share) | $ / shares			$ 0.001	$ 0.001
Pre Articles of Incorporation amendment authorized common stock (in shares) | shares				125,000,000
Preferred Stock
Number of shares issued (in shares) | shares	2,500,000
Number of investors | Investor	5
Proceeds from stock subscription agreements | $	$ 62,500
Series A convertible preferred stock, shares outstanding (in shares) | shares			13,602	13,602
Preferred stock, amount of preferred dividends in arrears | $			$ 153,000
Series A convertible preferred stock, liquidation preference (in dollars per share) | $ / shares			$ 25.00
Series A convertible preferred stock, dividend rate (in Percent)			6.50%
Valuation of dividends payable in shares, percent of the weighted average of common stock sales price on the last ten trading days ending on the third trading day prior to applicable dividend payment date (in Percent)			95.00%
Amount of dividend rate increase if distribution not made within five business days following dividend payment date (in Percent)			1.00%
Series A convertible preferred stock, increased dividend rate, if company fails to pay dividends within five days of dividend payment date (in Percent)			7.50%
Series A convertible preferred stock, dividend rate increased, if company fails to pay dividends on two consecutive dividend payment dates (in Percent)			10.00%
Preferred stock conversion price per share (in dollars per share) | $ / shares			$ 12.00
Minimum percent of closing stock price (in Percent)			140.00%
Notice period for Company redemption of preferred stock			30 days
Purchase price per share, percent of liquidation preference required of Company to holders of Series A Convertible Preferred Stock (in Percent)			100.00%
Purchase price per share, percent of liquidation preference required of Company on change of control (in Percent)			101.00%
Percent discounting of common stock value required if change of control triggers Company redemption of preferred stock, and Company elects to redeem via common stock issuance (in Percent)			5.00%
Purchase of preferred stock (in shares) | shares		93,570
Payment for the purchase and cancellation of Shares of Company Series A Convertible Preferred Stock | $		$ 58,000
Reversal of convertible preferred stock dividend accrual | $		$ 331,000
Share-Based Payments
Share-based compensation expense | $			$ 89,013	$ 63,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.001	$ 0.001
Share-based compensation, options outstanding (in shares) | shares		32,000	14,000,000
Share-based compensation, options outstanding, weighted average exercise price (in dollars per share) | $ / shares		$ 0.51	$ 0.14
Unrecognized compensation costs related to unvested equity awards, net of estimated forfeitures | $			$ 144,000
Options exercisable (in shares) | shares
Employee Stock Option [Member]
Share-Based Payments
Exercise price of options granted (in dollars per share) | $ / shares			$ 2.25	$ 0
Share-based compensation, options outstanding (in shares) | shares			14,000,000	32,000
Share-based compensation, options outstanding, weighted average exercise price (in dollars per share) | $ / shares			$ 0.136	$ 0.000
Share-based compensation, options outstanding, weighted average remaining contractual term			4 years 2 months 26 days	0 years
Unrecognized compensation costs related to unvested equity awards, net of estimated forfeitures | $			$ 97,000	$ 0
Options outstanding aggregate intrinsic value | $			$ 0	$ 0
Options exercisable (in shares) | shares			0	0
Employee Stock Option [Member] | $.05 per Share Price [Member] | Scientific Advisory Board Members [Member]
Authorized Capital Stock
Common stock, par value (in Dollars per share) | $ / shares			$ 0.001
Share-Based Payments
Share-based compensation, option awards, granted (in shares) | shares			2,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.001
Exercise price of options granted (in dollars per share) | $ / shares			$ 0.05
Number of options vesting on first anniversary from grant date (in shares) | shares			500,000
Number of options vesting monthly from grant date (in shares) | shares			62,500
Term of options vest monthly			24 months
Term of options			5 years
Employee Stock Option [Member] | $.25 per Share Price [Member] | Scientific Advisory Board Members [Member]
Authorized Capital Stock
Common stock, par value (in Dollars per share) | $ / shares			$ 0.001
Share-Based Payments
Share-based compensation, option awards, granted (in shares) | shares			1,500,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.001
Exercise price of options granted (in dollars per share) | $ / shares			$ 0.05
Term of options			5 years
Cumulative revenue targeted | $			$ 5,000,000